康哲药业（00867）于2026年8月3日披露2026年7月（截至7月31日）股份变动月报表。公告显示，公司法定注册股本为20,000,000,000股普通股，每股面值0.005美元，法定/注册股本总额保持在100,000,000美元，报告期内无新增或减少。
公司已发行股份(不含库存股份)于7月末维持在2,433,131,512股，库存股份6,397,000股，总已发行股份数为2,439,528,512股，较上月底无变化。公司确认截至报告期末，其公眾持股量满足香港联交所相关规定。当月无新增发行、购回、注销或库存股份变动，也无股份期权和股本激励计划的授出、行使或失效记录。
截至7月31日，公司股本整体保持稳定，未有任何发行或回购活动。公司同时声明，所有已完成的股份变动手续均遵守了香港联交所《上市规则》及相关法律规定。
公告由公司秘书吴三燕签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.